Lopez Santi Pilar, Bernard Jeremy, Fortuni Federico, Butcher Steele C, Meucci Maria Chiara, Sarrazyn Camille, Chua Aileen Paula, Nabeta Takeru, Zhang Jingnan, Popescu Bogdan A, Tay Edgar L W, Yiu Kai-Hang, Clavel Marie-Annick, Pibarot Philippe, Bax Jeroen J, Ajmone Marsan Nina
Department of Cardiology, Leiden University Medical Center, Albinusdreef 2, Leiden 2300 RC, The Netherlands.
Cardiology, Institut Universitaire de Cardiologie et de Pneumologie de Québec-Université Laval, Québec, Canada.
Eur Heart J Cardiovasc Imaging. 2025 Jul 31;26(8):1466-1474. doi: 10.1093/ehjci/jeaf165.
Left ventricular (LV) dilatation is an important prognostic factor in patients with aortic regurgitation (AR). Although current guidelines recommend the use of LV end-systolic diameter index (LVESDi) to indicate the need for intervention, recent studies suggested that LV end-systolic volume index (LVESVi) may more accurately characterize LV remodelling.The present study aims to evaluate, in a multi-centre setting, whether combining LV linear and volumetric measures could improve risk stratification.
A total of 1070 patients (56 ± 18 years, 65% male) with significant AR were included. Cut-off values of 20 mm/m2 for LVESDi and 45 mL/m2 for LVESVi were used to identify the following groups: no-significant LV dilatation (n = 485), when both LVESDi and LVESVi were below the cut-off values; discordant LV dilatation (n = 279) if only one positive criterium was present; and concordant LV dilatation (n = 306) when both LVESDi and LVESVi were enlarged. The primary endpoint was all-cause mortality. During a median follow-up of 7.4 (IQR, 4.5-11) years, 168 patients (16%) died, and 484 (45%) underwent aortic valve surgery (AVS). Patients with concordant LV dilatation showed the worst 10-year survival (P < 0.001). Discordant (HR 2.066, 95% CI 1.295-3.298; P = 0.002) or concordant LV dilatation (HR 2.759, 95% CI 1.616-4.710; P < 0.001) was independently associated with higher mortality compared with patients with no-significant LV dilatation after adjusting for relevant clinical and echocardiographic variables and regardless of AR severity. However, both groups showed greater benefit from AVS. LV dilatation, either concordant or discordant, was also independently associated with outcome in asymptomatic patients and those with left ventricular ejection fraction > 55%.
In patients with significant AR, the presence of LV dilatation detected by linear and/or volumetric measures was independently associated with increased mortality.
左心室(LV)扩张是主动脉瓣反流(AR)患者的一个重要预后因素。尽管当前指南推荐使用左心室收缩末期内径指数(LVESDi)来表明干预的必要性,但最近的研究表明,左心室收缩末期容积指数(LVESVi)可能更准确地表征左心室重构。本研究旨在多中心环境下评估,联合使用左心室线性和容积测量指标是否能改善风险分层。
共纳入1070例重度AR患者(56±18岁,65%为男性)。LVESDi的截断值为20 mm/m²,LVESVi的截断值为45 mL/m²,据此将患者分为以下几组:无显著左心室扩张组(n = 485),即LVESDi和LVESVi均低于截断值;不一致性左心室扩张组(n = 279),即仅存在一项阳性标准;一致性左心室扩张组(n = 306),即LVESDi和LVESVi均增大。主要终点为全因死亡率。在中位随访7.4(四分位间距,4.5 - 11)年期间,168例患者(16%)死亡,484例(45%)接受了主动脉瓣手术(AVS)。一致性左心室扩张患者的10年生存率最差(P < 0.001)。在校正相关临床和超声心动图变量后,无论AR严重程度如何,与无显著左心室扩张的患者相比,不一致性(HR 2.066,95%可信区间1.295 - 3.298;P = 0.002)或一致性左心室扩张(HR 2.759,95%可信区间1.616 - 4.710;P < 0.001)与更高的死亡率独立相关。然而,两组从AVS中均获益更大。一致性或不一致性左心室扩张在无症状患者以及左心室射血分数>55%的患者中也与预后独立相关。
在重度AR患者中,通过线性和/或容积测量指标检测到的左心室扩张与死亡率增加独立相关。